I am signing LOI with a Prague based B2B SaaS company. ~40 clients primarily in pharma and life science industries globally (mostly EU, growing in India, some of them big names). Modular product loved by users, 50% implementation time and cost vs. competition. Impressive TAM with solid organic growth. Potential to expand regionally and into new industries (FMCG, Energy) $1.6m ARR, +30% p.a., $700k EBITDA. Low churn. Price ~3x multiple. Seller financing available. Seeking equity investors who could help with expansion, primarily in the US, EU and India.